SHC1 encodes an adaptor protein that couples activated receptor tyrosine kinases to downstream signaling cascades. The protein exists in three isoforms with distinct functions: p46SHC and p52SHC, once phosphorylated by activated growth factor receptors, recruit the GRB2/SOS complex to initiate Ras-dependent mitogenic signaling 123; p66SHC does not activate Ras but instead mediates oxidative stress responses and apoptosis downstream of p53. SHC1 participates broadly in growth factor signaling, including erythropoietin, insulin, nerve growth factor, and T-cell receptor pathways, enabling activation of MAPK and PI3K cascades 45. The gene localizes to chromosome 1, a region subject to duplication in some malignancies. In disease contexts, SHC1 is implicated in multiple cancers: elevated SHC1 expression in lung adenocarcinoma and squamous cell carcinoma associates with poor overall survival 6, and aberrant HER2-SHCBP1-PLK1 axis activation reduces trastuzumab sensitivity in HER2-positive gastric cancer, with combination therapy using the SHCBP1-PLK1 inhibitor theaflavine-3,3'-digallate showing promise 7. Dysregulation of SHC1-mediated pathways also occurs in colorectal cancer and inflammatory conditions, where microRNA-452-mediated downregulation of SHC1 may provide a homeostatic defense mechanism 8.